Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice to develop a strategic, scientific approach toward tackling the Zika virus.
Zika virus disease is a mosquito-borne viral infection that primarily occurs in tropical and subtropical areas of the world.
It is related to other pathogenic vector borne flaviviruses including dengue, West-Nile and Japanese encephalitis viruses but produces a comparatively mild disease in humans
Genre: Flavivirus
Vector: Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours)
Reservoir: mosquitoes (gut, blood, saliva )
human ( blood, prostate, semen and testes )
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice to develop a strategic, scientific approach toward tackling the Zika virus.
Zika virus disease is a mosquito-borne viral infection that primarily occurs in tropical and subtropical areas of the world.
It is related to other pathogenic vector borne flaviviruses including dengue, West-Nile and Japanese encephalitis viruses but produces a comparatively mild disease in humans
Genre: Flavivirus
Vector: Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours)
Reservoir: mosquitoes (gut, blood, saliva )
human ( blood, prostate, semen and testes )
This lecture was prepared as a continuing medical education (CME) activity for the Philippine Obstetrical and Gynecological Society (POGS) Cebu chapter to update maternal health providers regarding the danger of Zika virus infection, particularly during pregnancy. This is a compilation of different literature materials available on the ongoing outbreaks of Zika virus infection in Latin America.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
This presentation summarizes what we know as of 10/27/16 about the connection between Zika virus and microcephaly, and what advice physicians could provide for their patients who are currently pregnant, or planning a pregnancy
Zika Virus is very Dangerous & a Silent Killer which is becoming Major cause of deaths in several countries around the World. Most of the people don't know about it in developed countries & the situation is worse in under-developed countries.
As a Doctor of Pharmacy, I (Dr. Ayesha Zaheer) prepared these Slides for spreading information about this Zika Virus so people know about it & its treatment. It is also useful for Students.
I hope it will be helpful.
Thanks & Regards,
Dr, Ayesha Zaheer
Updated Lecture about Zika virus .
Currently I am working in Arar Central Hospital, Arar city
In Saudi Arabia
Please do not hesitate to contact us if you require any further information.
Alsultany@hotmail.com
The Emergency Department (ED) is often at the center of some of the most controversial issues in health care reform. The cost of care, coordination of care, avoidable hospitalizations, misuse of the ED, and other issues have challenged hospitals to keep costs under control while delivering timely access, efficiency, and quality.
Today's challenges certainly create an imperative for change. But more importantly, hospitals must respond to a rapidly evolving health care environment, where the typical approach may not only become obsolete, it may be perilous.
Preparing for the future will require substantial changes. An accurate “diagnosis and treatment plan” is essential. And getting this “right” matters.
This lecture was prepared as a continuing medical education (CME) activity for the Philippine Obstetrical and Gynecological Society (POGS) Cebu chapter to update maternal health providers regarding the danger of Zika virus infection, particularly during pregnancy. This is a compilation of different literature materials available on the ongoing outbreaks of Zika virus infection in Latin America.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
This presentation summarizes what we know as of 10/27/16 about the connection between Zika virus and microcephaly, and what advice physicians could provide for their patients who are currently pregnant, or planning a pregnancy
Zika Virus is very Dangerous & a Silent Killer which is becoming Major cause of deaths in several countries around the World. Most of the people don't know about it in developed countries & the situation is worse in under-developed countries.
As a Doctor of Pharmacy, I (Dr. Ayesha Zaheer) prepared these Slides for spreading information about this Zika Virus so people know about it & its treatment. It is also useful for Students.
I hope it will be helpful.
Thanks & Regards,
Dr, Ayesha Zaheer
Updated Lecture about Zika virus .
Currently I am working in Arar Central Hospital, Arar city
In Saudi Arabia
Please do not hesitate to contact us if you require any further information.
Alsultany@hotmail.com
The Emergency Department (ED) is often at the center of some of the most controversial issues in health care reform. The cost of care, coordination of care, avoidable hospitalizations, misuse of the ED, and other issues have challenged hospitals to keep costs under control while delivering timely access, efficiency, and quality.
Today's challenges certainly create an imperative for change. But more importantly, hospitals must respond to a rapidly evolving health care environment, where the typical approach may not only become obsolete, it may be perilous.
Preparing for the future will require substantial changes. An accurate “diagnosis and treatment plan” is essential. And getting this “right” matters.
Dr. Tee (Thera) Fox, Veterinarian, Markdale Veterinary Services
Mosquito-borne virus infections of horses pose a continuous and expanding threat to equine health in Canada and internationally. The majority of equine mosquito-borne diseases in Canada today are preventable by immunization. What do we need to know to keep our Horses safe from these debilitating diseases? Topics covered will include: West Nile Virus (WNV), Eastern Equine Encephalitis (EEE), and Western Equine Encephalitis (WEE).
Resumen de enfermedades emergentes causadas por el arbovirus, que se transmiten a través de picaduras de mosquito. La posibilidad de afectación de los niños y de las mujeres embarazadas es una realidad que los pediatras tenemos que conocer.
From Burnout to Engagement: Strategies to Promote Physician Wellness and Work...Modern Healthcare
Slides from a Modern Healthcare presentation.
http://www.modernhealthcare.com/article/20150225/INFO/302259999/webinar-from-burnout-to-engagement-strategies-to-promote-physician
Faced with long hours, unrelenting administrative burdens and the pressure to treat patients quickly, a growing number of physicians are experiencing burnout, a condition characterized by loss of empathy, exhaustion, and a low sense of accomplishment. According to a Mayo Clinic survey from 2012, nearly one in two U.S physicians reported at least one symptom of burnout, up from 22% in 2001. For hospitals with stressed caregivers, the stakes are high. Burned out, dissatisfied physicians are far more likely to make medical errors and are less able to communicate effectively with patients and co-workers. They're also at a higher risk for substance abuse and are more likely to leave clinical practice altogether.
Three years ago, the Zika virus was nowhere to be found in the Western Hemisphere. But in 2015, Brazil suddenly found itself in the throes of an unprecedented Zika outbreak — with more than a million people infected by the mosquito-transmitted disease
Stephen Rawlings, MD, PhD
Clinical Fellow
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
Zika and Dengue: Creating Partnerships to Interrupt Transmission (Honein)Rotary International
Zika, a mosquito-borne virus, can be passed from a pregnant
woman to her fetus, potentially causing microcephaly and
other devastating defects. Environmental factors may
contribute to the spread of the viruses that cause Zika,
dengue, and other tropical diseases, as a changing climate
may allow their mosquito carriers to flourish. Though
no vaccines exist for Zika or dengue, Rotary clubs can
implement service projects to provide education, clean up
mosquito habitats, promote prevention, and implement
an exciting new method to interrupt mosquitoes’ ability to
transmit these viruses.
This is the first time in history that ZIKV has been associated with the development of adverse birth outcomes and has been linked to perinatal transmission. Little is known regarding the natural history, epidemiological transmission patterns, and major risk factors associated with ZIKV. Data on the outcomes of pregnancies in ZIKV infected women as well as specific trimesters when pregnant women are at highest risk for developing an adverse birth outcome remains sparse. This presentation discusses the epidemiological background and history of Zika Virus, preventative methods, and risk factors. In addition, the presentation discusses a research proposal to evaluate potential risk factors associated with the development of adverse birth outcomes in pregnant women with a laboratory confirmed diagnosis of ZIKV versus those Zika Virus infected pregnant women that did not develop adverse birth outcomes in three low-income regions of Northeastern Brazil.
Minji Kang, MD
Infectious Diseases Fellow
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
Zika Virus Surveillance and Reporting in the CaribbeanUWI_Markcomm
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice and developing a strategic, scientific approach to tackling the Zika virus.
Disclaimer -
The Content belongs to WHO (World Health Organisation). Sharing here is just to spread awareness about Covid-19.
https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update37-vaccine-development.pdf?sfvrsn=2581e994_6
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice to develop a strategic, scientific approach for tackling the Zika virus.
Shifting landscapes: Establishing and maintaining brand identity in an era of...Modern Healthcare
As the healthcare system continues its unprecedented trend of consolidation, driven by factors such as the rapid move to value-based care, many hospitals and health systems wonder how a merger or acquisition might affect their hard-earned brand identity and reputation. This session will explore that question in depth as speakers from Baylor Scott & White Health, the largest not-for-profit health system in Texas formed in 2013 after an $8.3 billion merger of two well-known healthcare organizations, share lessons learned and offer practical marketing and branding strategies.
The power of the story: Using patient testimonials and stories to drive marke...Modern Healthcare
Nothing drives a message home like a well-told story. And an increasing number of healthcare organizations are making patient testimonials a central part of their marketing strategy, harnessing the power of a compelling story to build loyalty, highlight compelling cases and showcase their best work. In this session, experts will share best practices—and common pitfalls—to keep in mind when using patient testimonials.
The tools for success: Leveraging content marketing to engage and inspirefor ...Modern Healthcare
Developing an insightful content marketing strategy that anticipates consumers’ need for meaningful health information can go a long way toward helping healthcare organizations reach their target audiences and build relationships. But many marketers, wary of navigating this heavily regulated area, have made scant progress. This plenary session will dive deep into the ins and outs of content marketing, including tips for choosing the right channels and effective techniques for measuring your efforts.
Webinar: Information Governance - Where is the Healthcare Industry and Where ...Modern Healthcare
Led by Deborah Green, MBA, RHIA EVP/Chief Innovation and Global Services Officer of AHIMA, who has had key responsibility for AHIMA's IG initiative, and featuring Katherine Lusk, MHSM, RHIA is the Chief Health Information Management and Exchange Officer for Children's Medical Health System of Texas, who has been instrumental in promoting and shepherding information governance (IG) at her organization, this webinar will provide insights on key findings of the second survey of IG adoption in Healthcare. The webinar will feature:
- Specific findings on progress in IG adoption
- A discussion of the evolving disciplines of IG
- Perspectives on the readiness and needs of professionals working in IG and related roles
The Leadership Pipeline: Cultivating Your Organization’s High Potential Emplo...Modern Healthcare
The Leadership Pipeline: Cultivating Your Organization’s High Potential Employees – Joseph Cabral at Modern Healthcare's 8th annual Workplace of the Future Conference on Wednesday, October 14, 2015 at the Omni Hotel in Nashville Tennessee.
Workplace Wellness in Flux – Nicolaas Pronk at Modern Healthcare's 8th annual Workplace of the Future Conference on Wednesday, October 14, 2015 at the Omni Hotel in Nashville Tennessee.
Opening Keynote Presentation – George Foyo at Modern Healthcare's 8th annual Workplace of the Future Conference on Wednesday, October 14, 2015 at the Omni Hotel in Nashville Tennessee.
Closing Keynote Presentation – Craig Deao at Modern Healthcare's 8th annual Workplace of the Future Conference on Wednesday, October 14, 2015 at the Omni Hotel in Nashville Tennessee.
Workplace Wellness in Flux – Daniel Timblin at Modern Healthcare's 8th annual Workplace of the Future Conference on Wednesday, October 14, 2015 at the Omni Hotel in Nashville Tennessee.
EHR Safety - Identifying and Mitigating Health IT-related Risks (Webinar Slides)Modern Healthcare
About the Webinar
The federal government has spent tens of billions of dollars getting providers to install EHR systems-all in the hopes of making care more efficient, safe and cost-effective. But EHRs can introduce their own safety risks, whether from confusing displays, excessive alerts or a range of other factors. This hourlong webinar will explore where we are now on health IT-related safety and what you can do to mitigate hazards in your own organization.
You can learn more about this event:
http://www.modernhealthcare.com/article/20150908/WEBINAR/309099998/webinar-ehr-safety-identifying-and-mitigating-health-it-related-risks
Custom webinar slides: Improve operations through standardizationModern Healthcare
Listen to operational leaders from Baptist Health South Florida and Ochsner Health System describe the growth and optimization strategies that generated results for their organizations. Hear lessons learned and insights that led to increased operational performance and innovative culture. Learn about the journey of driving cultural and systemic change that breaks down silos and builds an efficient integrated system. Topics that will be addressed by the panel include:
- Establish and strengthen strategic partnerships and alliances to drive growth
- Foster a collaborative and innovative culture
- Increase productivity and cost savings
- Create vendor score cards that maximize value and performance
More information can be found here:
http://www.modernhealthcare.com/article/20150715/SPONSORED/307169999
Achieving Sustainable Savings in Purchased Services Through Best PracticesModern Healthcare
Purchased-service agreements present an area of potential savings for operational budgets if hospitals have the right data, research and tools to control and reprioritize their purchased-services spending.
Join us as we learn how SSM Health, a four-state non-profit health care system, implemented a best-practices approach to purchased services to secure large-dollar savings across its entire purchased-services spend. During this webinar Cris O'Neal-Gavin, System Contract manager for Purchased Services at SSM Health, will share how they drove savings in large national purchased-services categories, and achieved even larger savings in more strategic regional services. Also get exclusive access to MD Buyline's most recent research showcasing how the nation's most innovative hospitals are implementing common strategies to reduce the cost and complexity of purchased-services contracts.
Webinar: Leading the Journey - Cultivating Success in HealthcareModern Healthcare
The fifth annual Huron Healthcare CEO Forum brought together dozens of the most experienced executives in hospitals and health systems across the country to address challenges, share experiences and assess high-level strategies to achieve success in the year ahead. The Forum also featured executives from leading brands outside healthcare, such as The Home Depot and Coca-Cola, who shared valuable and applicable advice for navigating the rapidly changing healthcare environment.
Two of the three largest data breaches in healthcare industry history have occurred in the past six months – exposing personally identifiable patient and health plan membership records on 84.5 million individuals – a number equal to the populations of California, Texas, New York and Nevada combined. Both breaches were attributed to hackers from China. These, and other massive hacks in financial services and retail, prompted President Obama to sign an executive order in February calling on government and the private sector to step up the nation's defenses against cybersecurity threats.
As pressure mounts on hospitals to improve quality and reduce costs, they have turned to medicine's fastest growing physician specialty—hospital medicine---to improve clinical performance and operational efficiency. How this new role for hospitalists plays out varies according to the type, location and creativity of individual healthcare organizations and the resources available to them. This editorial webinar will explore the steps health care organizations should take to prepare and position their hospitalists for quality-improvement responsibilities. Our panel of experts will share their insights, experiences and proven strategies for success.
Webinar: Bad Data's Effect on Population Health PerformanceArcadia webinar da...Modern Healthcare
Managing complex patient populations requires comprehensive and reliable EHR data. Join Beth Israel Deaconess Care Organization and Arcadia Healthcare Solutions to learn how to properly assess your EHR data to ensure you have the right information to make key strategic decisions. This webinar will explore three ways to identify data quality issues.
Webinar: Why Hospitalists are Important to Managing Population HealthLp cogen...Modern Healthcare
This webinar will outline the changing healthcare environment, and illustrate how a strong hospital medicine program is critical to meet population health goals. Led by former Utah Gov. Michael O. Leavitt, also former secretary of HHS, this distinguished panel will lend insight and detail from the perspective of the government, healthcare leadership and hospital medicine pioneers.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
3. NOW SPEAKING
Please use the questions box on your webinar
dashboard to submit questions to our moderator
JACLYN SCHIFF
Moderator
Editorial Programs Manager
Modern Healthcare
WEBINAR SERIES
From Ebola to Zika:
What Do Providers Need to Know?
S P O N S O R ED BY
4. During today’s discussion, feel free to submit questions at any time by using the questions box
DR. MICHAEL BELL
Deputy Director
National Center for Emerging
and Zoonotic Infectious Diseases
JOHN BRADEN
Medical Director, Emergency
Preparedness
Baptist Health South Florida
JACLYN SCHIFF
Moderator
Editorial Programs Manager
Modern Healthcare
COL. MICHAEL RAJNIK, USAF
Associate Professor
of Pediatrics
Uniformed Services University
JOHN BRADEN
Medical Director,
Emergency Preparedness
Baptist Health South Florida
TODAY’S PANELISTS
WEBINAR SERIES
From Ebola to Zika:
What Do Providers Need to Know?
S P O N S O R ED BY
5. NOW SPEAKING
Please use the questions box on your webinar
dashboard to submit questions to our moderator
DR. MICHAEL BELL
Deputy Director
National Center for
Emerging and Zoonotic
Infectious Diseases
WEBINAR SERIES
From Ebola to Zika:
What Do Providers Need to Know?
S P O N S O R ED BY
6. Centers for Disease Control and Prevention
Zika Virus
Update on Interim Zika Virus Clinical Guidance and
Recommendations
Michael Bell, MD
Deputy Director,
Division of Healthcare Quality Promotion,
Centers for Disease Control and Prevention
March 24, 2016
7. Zika Virus
Single stranded RNA virus (Genus Flavivirus)
Related to dengue, yellow fever, Japanese
encephalitis, West Nile
Transmitted to humans primarily by Aedes
(Stegomyia) species mosquitoes
• Ae aegypti (more efficient vectors to humans)
• Ae albopictus
Also transmit dengue and chikungunya viruses
Live indoors and outdoors
Aggressive daytime biters; can also bite at night
8. Zika Virus in the United States
Local vector-borne transmission of Zika
virus has not been reported in the
continental United States
With current outbreak in the Americas,
cases among U.S. travelers will likely
increase
Imported cases may result in virus
introduction and local transmission in
some areas of U.S.
9. Other Possible Modes of Transmission
Maternal-fetal
• Intrauterine
• Perinatal
Sexual Contact
• Pregnant women with male partners who have or are
at risk of Zika virus infection should abstain or use
condoms for the duration of pregnancy
Other
• Blood transfusion
• Organ or tissue transplantation
10. Zika Virus Disease Symptoms
Clinical illness usually mild, non-specific
Symptoms last several days to a week
Common symptoms:
• Rash
• Fever
• Joint pain
• Conjunctivitis (red eyes)
Less common:
• Muscle pain
• Headache
Severe disease and fatalities are rare
Guillain-Barré syndrome reported in some patients following
suspected Zika virus infection
Assessment of links between Zika virus and microcephaly and
outcomes ongoing
11. Initial Assessment and Treatment
No specific antiviral therapy
Treatment is supportive (i.e., rest, fluids, analgesics, antipyretics)
Suspected Zika virus infections should be evaluated for possible dengue
or chikungunya virus infections
Aspirin and other NSAIDs should be avoided until dengue can be ruled
out to reduce the risk of hemorrhage
Avoid aspirin in children with suspected viral infection due to the
association with Reye’s syndrome
12. Reporting Zika Virus Disease Cases
Zika virus disease is a nationally notifiable disease
• Healthcare providers are encouraged to report cases with laboratory
evidence of Zika infection to their state, tribal, local, or territorial
health department
Health departments are requested to report cases with laboratory
evidence of Zika infection to CDC
Timely reporting allows health departments to assess and reduce the risk
of local transmission or mitigate further spread
13. Diagnostic tests:
For acute illness (symptoms present for <7 days):
Detect Zika virus RNA by RT-PCR for serum and/or cerebrospinal fluid
If Zika virus RNA is not detected and symptoms have been present for ≥4 days
Zika and dengue virus IgM and neutralizing antibodies
Feb. 2016, FDA issued an Emergency Use Authorization (EUA) for CDC Zika IgM
Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA)
CDC distributing test kits via the Laboratory Response Network
More information about laboratory testing can be found at:
http://www.cdc.gov/zika/state-labs/index.html
14. Interim recommendations for testing
Pregnant women should be tested:
• History of travel to an area with Zika virus transmission during
pregnancy AND :
• Presence of two or more of the following symptoms (acute onset
of fever, maculopapular rash, arthralgia, or conjunctivitis) during
travel or within 2 weeks of travel
OR
• Presence of fetal microcephaly or intracranial calcification by
ultrasound
15. Zika Virus Infection and Pregnancy: Clinical
Management
Positive or inconclusive Zika virus testing results
– Antepartum
• Consider serial ultrasounds every 3–4 weeks
• Referral to maternal-fetal medicine specialist is recommended
– Postpartum
• Histopathologic examination of the placenta and umbilical cord
• Testing of frozen placental tissue and cord tissue for Zika virus RNA
• Testing of cord serum for Zika and dengue virus IgM and neutralizing
antibodies
16. Preventing Zika Virus Transmission in Labor and
Delivery and Health Care Settings
Standard Precautions for preventing
transmission in healthcare settings
http://www.cdc.gov/mmwr/volumes/65/wr/mm6511e3er.htm
?s_cid=mm6511e3er_w
18. Additional resources
CDC Zika virus information: http://www.cdc.gov/zika/
Zika virus information for clinicians: http://www.cdc.gov/zika/hc-
providers/index.html
Zika virus information for travelers and travel health providers:
http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-
related-to-travel/zika
Travel notices: http://wwwnc.cdc.gov/travel/notices
19. NOW SPEAKING
Please use the questions box on your webinar
dashboard to submit questions to our moderator
COL. MICHAEL
RAJNIK, USAF
Associate Professor of Pediatrics
Uniformed Services University
WEBINAR SERIES
From Ebola to Zika:
What Do Providers Need to Know?
S P O N S O R ED BY
20. Emerging Infections 2016
Zika Virus: A Military Perspective
Emerging Infections 2016
Zika Virus: A Military Perspective
Michael Rajnik, Col, USAF, MC
Associate Professor of Pediatrics
F. Edward Hebert School of Medicine
Uniformed Services University of the Health
Sciences
Michael Rajnik, Col, USAF, MC
Associate Professor of Pediatrics
F. Edward Hebert School of Medicine
Uniformed Services University of the Health
Sciences
21. Why is Zika a Concern for the DoD?Why is Zika a Concern for the DoD?
• Force Health Protection
• All services performed, provided, or arranged
by the Services to promote, improve,
conserve, or restore the mental or physical
well-being of personnel.
• We have uniformed and civilian personnel
stationed and deployed all over the world
• We have the largest global health network
• Force Health Protection
• All services performed, provided, or arranged
by the Services to promote, improve,
conserve, or restore the mental or physical
well-being of personnel.
• We have uniformed and civilian personnel
stationed and deployed all over the world
• We have the largest global health network
22. The United States Army Yellow Fever
Commission
The United States Army Yellow Fever
Commission
• Mosquito was the
vector of
transmission for
Yellow Fever
• Human Subject
experiments
implementing
volunteers with
informed consent
• Mosquito was the
vector of
transmission for
Yellow Fever
• Human Subject
experiments
implementing
volunteers with
informed consent
23. Why is Zika a Concern for the DoD?
Research
Why is Zika a Concern for the DoD?
Research
• Walter Reed Army Institute of Research
Viral Diseases Branch (WRAIR)
• Dengue Virus Research and Immunization
Development
• Working on immunization with
GlaxoSmithKline
• Adjuvanted, Purified, Inactivated Dengue Virus
Vaccine, Types 1-4 (DPIV)
• Investigating Zika Constructs
• Walter Reed Army Institute of Research
Viral Diseases Branch (WRAIR)
• Dengue Virus Research and Immunization
Development
• Working on immunization with
GlaxoSmithKline
• Adjuvanted, Purified, Inactivated Dengue Virus
Vaccine, Types 1-4 (DPIV)
• Investigating Zika Constructs
24. Why is Zika a Concern for the DoD?
Research
Why is Zika a Concern for the DoD?
Research
• January 27, 2016
• DoD to assist Health and Human Services in
Zika Virus Research
• Defense Threat Reduction Agency
• United States Army Medical Research Institute
of Infectious Diseases (USAMRIID)
• Hope that infrastructure might be used to
help “fast-track” research efforts similar to
the Ebola Response
• January 27, 2016
• DoD to assist Health and Human Services in
Zika Virus Research
• Defense Threat Reduction Agency
• United States Army Medical Research Institute
of Infectious Diseases (USAMRIID)
• Hope that infrastructure might be used to
help “fast-track” research efforts similar to
the Ebola Response
25. Options for Pregnant Women Outside
of the US Affected by Zika Virus
Options for Pregnant Women Outside
of the US Affected by Zika Virus
• The option is up to the local commanders
and or Combatant Commanders
• The option is up to the local commanders
and or Combatant Commanders
26. Pregnant Uniformed Service MembersPregnant Uniformed Service Members
• Service Members
• Temporary Duty (TDY)
• May be relocated to an area where no active
transmission is occurring for duration of
pregnancy
• Early Change of Station (PCS)
• Move to next station outside of transmission zone
• Result in a gap in personnel
• Service Members
• Temporary Duty (TDY)
• May be relocated to an area where no active
transmission is occurring for duration of
pregnancy
• Early Change of Station (PCS)
• Move to next station outside of transmission zone
• Result in a gap in personnel
27. Pregnant Dependents of Uniformed
Service Members
Pregnant Dependents of Uniformed
Service Members
• Dependents
• Medical Care Travel from a Zika-affected area
• Early Return of Dependents (ERD)
• Will pay for travel and household goods
shipments
• Cannot return to the duty station unless another
tour is authorized
• Travel at the Personal Expense of the Service
Member’s Dependent
• This might impact the Service Member’s
Benefits
• Dependents
• Medical Care Travel from a Zika-affected area
• Early Return of Dependents (ERD)
• Will pay for travel and household goods
shipments
• Cannot return to the duty station unless another
tour is authorized
• Travel at the Personal Expense of the Service
Member’s Dependent
• This might impact the Service Member’s
Benefits
28. Pregnant DoD CiviliansPregnant DoD Civilians
• Temporary Duty (TDY)
• Orders back to the US for duration of pregnancy
• May be transitioned to medical care travel for birth
• Dependents may travel at Govt expense of ERD
• Medical Care Travel
• May leave 6 weeks before and stay 6 weeks after
– up to 180 days
• Release from Transportation Agreement
• Duty Status – Maximize Telework
• Priority Placement Program (PPP) eligible
• Temporary Duty (TDY)
• Orders back to the US for duration of pregnancy
• May be transitioned to medical care travel for birth
• Dependents may travel at Govt expense of ERD
• Medical Care Travel
• May leave 6 weeks before and stay 6 weeks after
– up to 180 days
• Release from Transportation Agreement
• Duty Status – Maximize Telework
• Priority Placement Program (PPP) eligible
29. Pregnant Dependents of DoD CiviliansPregnant Dependents of DoD Civilians
• Medical Travel
• May leave Zika virus-affected country for 6 weeks
before and 6 weeks after delivery
• Up to 180 days
• ERD
• Command may return permanently if in the best
interest of the Government
• May not rejoin her family
• Travel at own personal expense
• May rejoin with child at own expense
• Medical Travel
• May leave Zika virus-affected country for 6 weeks
before and 6 weeks after delivery
• Up to 180 days
• ERD
• Command may return permanently if in the best
interest of the Government
• May not rejoin her family
• Travel at own personal expense
• May rejoin with child at own expense
30. Received Orders but are Pregnant or
Dependents are Pregnant
Received Orders but are Pregnant or
Dependents are Pregnant
• Cancellation of PCS
• Service or Agency may cancel PCS orders or
delay the report date until after birth of child
• Delayed Dependent Travel
• If it is a dependent who is pregnant, travel of
dependents can be delayed until after the birth
of the child
• Cancellation of PCS
• Service or Agency may cancel PCS orders or
delay the report date until after birth of child
• Delayed Dependent Travel
• If it is a dependent who is pregnant, travel of
dependents can be delayed until after the birth
of the child
31. Comprehensive Force Health
Protection
Comprehensive Force Health
Protection
• Reduce Mosquito Population, Avoid
Mosquito bites, and Prevent Infection
• Communication
• Mosquito surveillance and Control
• Proper wear of Uniforms/Clothing
• Insect Repellents (Permethrin and DEET)
• Bed Nets
• Screening of Living Quarters
***** DEET and Permethrin-Treated Clothing are
safe in Pregnancy *****
• Reduce Mosquito Population, Avoid
Mosquito bites, and Prevent Infection
• Communication
• Mosquito surveillance and Control
• Proper wear of Uniforms/Clothing
• Insect Repellents (Permethrin and DEET)
• Bed Nets
• Screening of Living Quarters
***** DEET and Permethrin-Treated Clothing are
safe in Pregnancy *****
32. The Walter Reed National Military
Medical Center-Bethesda Experience
The Walter Reed National Military
Medical Center-Bethesda Experience
• Large referral center for the National
Capital Region also receiving transfers
from outside of the United States
• Active Infectious Diseases Services (Adult
and Pediatric) with robust Perinatology
support for High-Risk Pregnancies
• Similar facilities in HI, TX, VA, WA, CA
• Large referral center for the National
Capital Region also receiving transfers
from outside of the United States
• Active Infectious Diseases Services (Adult
and Pediatric) with robust Perinatology
support for High-Risk Pregnancies
• Similar facilities in HI, TX, VA, WA, CA
33. The Walter Reed National Military
Medical Center-Bethesda Experience
The Walter Reed National Military
Medical Center-Bethesda Experience
• Patients with exposure to Zika endemic areas
and clinical symptoms or pregnancy have been
referred to this system
• History – Travel, Immunizations, Symptoms
• Clinical Assessment of patient
• Sampling for Zika Virus, Dengue and
Chikungunya
• Testing sent to referral area where the patient
lives (State labs in MD, VA or CDC)
• Working on in-house testing
• Navy Infectious Diseases Diagnostic Lab (NIDDL)
• Patients with exposure to Zika endemic areas
and clinical symptoms or pregnancy have been
referred to this system
• History – Travel, Immunizations, Symptoms
• Clinical Assessment of patient
• Sampling for Zika Virus, Dengue and
Chikungunya
• Testing sent to referral area where the patient
lives (State labs in MD, VA or CDC)
• Working on in-house testing
• Navy Infectious Diseases Diagnostic Lab (NIDDL)
34. The Walter Reed National Military
Medical Center-Bethesda Experience
The Walter Reed National Military
Medical Center-Bethesda Experience
• Screened
• 27 high-risk patients
• Exposure + symptoms or pregnant
• Pregnant referred to Obstetrics per the CDC
guidelines
• 1 positive Zika, 1 likely Dengue and no
evidence of congenital infections
• Screened
• 27 high-risk patients
• Exposure + symptoms or pregnant
• Pregnant referred to Obstetrics per the CDC
guidelines
• 1 positive Zika, 1 likely Dengue and no
evidence of congenital infections
35. NOW SPEAKING
Please use the questions box on your webinar
dashboard to submit questions to our moderator
JOHN BRADEN
Medical Director,
Emergency Preparedness
Baptist Health South Florida
WEBINAR SERIES
From Ebola to Zika:
What Do Providers Need to Know?
S P O N S O R ED BY
37. Baptist Health by the Numbers
• 7 Hospitals
•50+ Outpatient Centers, Medical Plazas
and other facilities
•Spans 4 counties
•16,000+ total employees
•347,000 Yearly Emergency Visits
47. THANKS ALSO
TO OUR
PANELISTS:
EXPECT A FOLLOW-UP EMAIL within two weeks
with links to presentation materials and
information about how to offer feedback.
FOR MORE INFORMATION about
upcoming webinars, please visit
ModernHealthcare.com/webinars
THANK YOU FOR ATTENDING
DR. MICHAEL BELL
Deputy Director
National Center for Emerging
and Zoonotic Infectious Diseases
JACLYN SCHIFF
Moderator
Editorial Programs Manager
Modern Healthcare
COL. MICHAEL RAJNIK, USAF
Associate Professor
of Pediatrics
Uniformed Services University
JOHN BRADEN
Medical Director,
Emergency Preparedness
Baptist Health South Florida
From Ebola to Zika:
What Do Providers Need to Know?WEBINAR SERIES
From Ebola to Zika:
What Do Providers Need to Know?
S P O N S O R ED BY